BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23393267)

  • 1. Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.
    Zang YS; Fang Z; Li B
    Am J Hosp Palliat Care; 2013 Mar; 30(2):210-3. PubMed ID: 23393267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To feed or not to feed: is that the right question?
    Moynihan T; Kelly DG; Fisch MJ
    J Clin Oncol; 2005 Sep; 23(25):6256-9. PubMed ID: 16135494
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
    LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
    Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anorexia and cachexia in neoplastic diseases].
    Liubenov T
    Vutr Boles; 1982; 21(5):10-5. PubMed ID: 6819714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Anorexia and Cachexia: Screening in an Ambulatory Infusion Service and Nutrition Consultation
.
    Berry DL; Blonquist T; Nayak MM; Roper K; Hilton N; Lombard H; Hester A; Chiavacci A; Meyers S; McManus K
    Clin J Oncol Nurs; 2018 Feb; 22(1):63-68. PubMed ID: 29350696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer.
    Smith J
    Clin Ther; 2005 Oct; 27(10):1513-34. PubMed ID: 16330289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anorexia-cachexia syndrome in bronchial carcinoma--pathophysiology therapeutic approaches].
    Heckmayr M
    Pneumologie; 2003 Jun; 57(6):328-34. PubMed ID: 12813668
    [No Abstract]   [Full Text] [Related]  

  • 8. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.
    Nanda A; Dias-Santagata DC; Stubbs H; O'Hara CJ; Zaner KS; Lynch TJ; Willers H
    Clin Lung Cancer; 2008 Sep; 9(5):285-7. PubMed ID: 18824451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer cachexia syndrome in patients with lung cancer].
    Jankowska R; Kosacka M
    Wiad Lek; 2003; 56(7-8):308-12. PubMed ID: 14969155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erlotinib effective against refractory bronchorrhea from advanced non-small cell lung cancer.
    Thotathil Z; Long J
    J Thorac Oncol; 2007 Sep; 2(9):881-2. PubMed ID: 17805071
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancer.
    Bradbury PA; Tu D; Seymour L; Isogai PK; Zhu L; Ng R; Mittmann N; Tsao MS; Evans WK; Shepherd FA; Leighl NB;
    J Natl Cancer Inst; 2010 Mar; 102(5):298-306. PubMed ID: 20160168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cachexia-anorexia syndrome among oncological patients].
    Sosa-Sánchez R; Sánchez-Lara K; Motola-Kuba D; Green-Renner D
    Gac Med Mex; 2008; 144(5):435-40. PubMed ID: 19043964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer.
    Hotta K; Kiura K
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):991-7. PubMed ID: 21806322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
    Inui A
    Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern treatment of lung cancer: case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinoma.
    Garfield DH
    J Clin Oncol; 2005 Oct; 23(30):7738-40. PubMed ID: 16234533
    [No Abstract]   [Full Text] [Related]  

  • 16. Anorexia and cachexia in advanced cancer patients.
    Vigano A; Watanabe S; Bruera E
    Cancer Surv; 1994; 21():99-115. PubMed ID: 8565002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging a Team Mental Model to Develop a Cancer Anorexia-Cachexia Syndrome Team.
    Portman DG; Thirlwell S; Donovan KA; Alvero C; Gray JE; Holloway R; Ellington L
    J Oncol Pract; 2016 Nov; 12(11):1046-1052. PubMed ID: 27858539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VEGF in the cancer anorexia-cachexia syndrome in patients with lung cancer].
    Weryńska B; Kosacka M; Gołecki M; Jankowska R
    Pneumonol Alergol Pol; 2006; 74(2):186-90. PubMed ID: 17269367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the pharmacological treatment of cancer cachexia possible?
    Bruera E
    Support Care Cancer; 1993 Nov; 1(6):298-304. PubMed ID: 8156247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions].
    Ockenga J; Pirlich M; Gastell S; Lochs H
    Z Gastroenterol; 2002 Nov; 40(11):929-36. PubMed ID: 12436371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.